Literature DB >> 7700643

Suppression of growth factor-mediated MAP kinase activation by v-raf in macrophages: a putative role for the MKP-1 phosphatase.

S Krautwald1, D Büscher, P Dent, K Ruthenberg, M Baccarini.   

Abstract

Many tyrosine kinase growth factor receptors activate the MAP Kinase (MAPK) pathway by stimulating the activity of the RAF kinase. In some, but not all cell types, the expression of activated RAF is sufficient to induce constitutive MAPK activation. In BAC-1.2F5 macrophages the expression of virally activated RAF does not correlate with constitutive MAPK activation; on the contrary, growth factor-mediated stimulation of MAPK activity is suppressed in these cells. Suppression correlates with v-RAF expression, as MAPK activation is normal in a revertant cell line that stopped expressing v-RAF. Inhibition of MAPK activation is associated with lack of ERK-2 tyrosine phosphorylation, and is not due to the suppression of CSF-1-mediated MEK activation. Pretreatment with vanadate restores growth factor-stimulated activation and tyrosine phosphorylation of MAPK in v-RAF-expressing macrophages, indicating the involvement of a tyrosine phosphatase. Interestingly, v-RAF-expressing macrophages contain low constitutive levels of MKP-1 mRNA, an immediate early gene that encodes a MAPK-specific phosphatase and is induced in the parental cell line by CSF-1 treatment. The restoration of MAPK activation by vanadate pretreatment and the presence of MKP-1 mRNA in v-RAF-expressing macrophages raise the intriguing possibility that in macrophages RAF may be feeding back on the MAPK pathway by participating in the control of MKP-1 expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7700643

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway.

Authors:  K M Pumiglia; S J Decker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 2.  Mitogen-activated protein kinase phosphatase 1 (MKP-1) in macrophage biology and cardiovascular disease. A redox-regulated master controller of monocyte function and macrophage phenotype.

Authors:  Hong Seok Kim; Reto Asmis
Journal:  Free Radic Biol Med       Date:  2017-03-19       Impact factor: 7.376

3.  Involvement of the protein tyrosine phosphatase SHP-1 in Ras-mediated activation of the mitogen-activated protein kinase pathway.

Authors:  S Krautwald; D Büscher; V Kummer; S Buder; M Baccarini
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

4.  Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells.

Authors:  E M Weissinger; G Eissner; C Grammer; S Fackler; B Haefner; L S Yoon; K S Lu; A Bazarov; J M Sedivy; H Mischak; W Kolch
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

5.  Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling.

Authors:  G Müller; P Storz; S Bourteele; H Döppler; K Pfizenmaier; H Mischak; A Philipp; C Kaiser; W Kolch
Journal:  EMBO J       Date:  1998-02-02       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.